NEW YORK (GenomeWeb News) — Arrayit has licensed its microarray platform and associated reagents to Belmedtechnika, an equipment provider in Belarus, Arrayit said yesterday.
Arrayit, a subsidiary of Integrated Media Holdings, said that Belmedtechnika will deploy its high-throughput genotyping platform to screen and test number patient samples "quickly, affordably, and accurately."
The licensing agreement permits Belmedtechnika to use Arrayit's multi-patient platform to examine many patients' DNA samples at one time. Belmedtechnika also gained the right to use Arrayit's contact printing technology for diagnostic applications.
Financial terms of the agreement were not released.